Next week, our colleagues Daniel Hoppe, Yasmine Azzaoui and Dr. Sarah Salaschek will be attending the 2nd Annual Pharma and Biotech Patent Litigation North America taking place in Philadelphia on November 18-19, 2025, as we proudly serve as Gold Partners.

We are delighted to have our partner Daniel Hoppe participating as a speaker in the key session “Understanding the Status of the UPC and Its Implications for U.S. Life Science Companies” on November 18 at 1:45 PM. This session will provide a clear overview of how the UPC functions, what recent decisions reveal about its direction, and why U.S.-based life science patent owners should be paying close attention. Participants will explore the strategic advantages the UPC offers, such as streamlined enforcement across multiple EU countries, speedier proceedings, and the potential to strengthen global patent value, and how best to integrate it into a transatlantic patent strategy.

Thanks to Global IP Strategy Hub, IP Strategy Hub US and Kisaco Research for organizing this event!

November 18–19, 2025
Philadelphia Marriott Downtown (Philadelphia, PA, USA)
More information